Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bauer

Showing results (1561-1570 of 1,614) with videos related to

Pageof 162
Sort By:
Journal of Occupational Medicine and Toxicology (London, England)|September 18, 2020
Basal cell carcinoma risk and solar UV exposure in occupationally relevant anatomic sites: do histological subtype, tumor localization and Fitzpatrick phototype play a role? A population-based case-control studyA Bauer, E Haufe, L Heinrich, et al.
The British Journal of Dermatology|August 29, 2017
Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181J Schmitt, E Haufe, F Trautmann, et al.
BMC Complementary Medicine and Therapies|January 9, 2026
Effectiveness of tuina and physiotherapy to manage pain for patients with chronic low back pain: a pragmatic randomized clinical trialIa Choo Celia Tan, Hao En Matthew Wong, Fan Qiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiationJoshua A Bauer, A Bapsi Chakravarthy, Jennifer M Rosenbluth, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Science Translational Medicine|March 13, 2020
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitorsJohanna M Schafer, Brian D Lehmann, Paula I Gonzalez-Ericsson, et al.
Blood|August 13, 2016
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myelomaNiels Weinhold, Cody Ashby, Leo Rasche, et al.
Journal of Medicinal Chemistry|November 15, 2019
Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5-MYC Protein-Protein InteractionJonathan D Macdonald, Selena Chacón Simon, Changho Han, et al.
Journal of Medicinal Chemistry|November 3, 2012
Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687)Jonas G Barlind, Udo A Bauer, Alan M Birch, et al.
The British Journal of Dermatology|January 19, 2016
Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN)J Schmitt, S Deckert, M Alam, et al.
Pageof 162

Showing results (1561-1570 of 1,614) with videos related to

Sort By:
Pageof 162
Journal of Occupational Medicine and Toxicology (London, England)|September 18, 2020
Basal cell carcinoma risk and solar UV exposure in occupationally relevant anatomic sites: do histological subtype, tumor localization and Fitzpatrick phototype play a role? A population-based case-control studyA Bauer, E Haufe, L Heinrich, et al.
The British Journal of Dermatology|August 29, 2017
Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181J Schmitt, E Haufe, F Trautmann, et al.
BMC Complementary Medicine and Therapies|January 9, 2026
Effectiveness of tuina and physiotherapy to manage pain for patients with chronic low back pain: a pragmatic randomized clinical trialIa Choo Celia Tan, Hao En Matthew Wong, Fan Qiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiationJoshua A Bauer, A Bapsi Chakravarthy, Jennifer M Rosenbluth, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Science Translational Medicine|March 13, 2020
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitorsJohanna M Schafer, Brian D Lehmann, Paula I Gonzalez-Ericsson, et al.
Blood|August 13, 2016
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myelomaNiels Weinhold, Cody Ashby, Leo Rasche, et al.
Journal of Medicinal Chemistry|November 15, 2019
Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5-MYC Protein-Protein InteractionJonathan D Macdonald, Selena Chacón Simon, Changho Han, et al.
Journal of Medicinal Chemistry|November 3, 2012
Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687)Jonas G Barlind, Udo A Bauer, Alan M Birch, et al.
The British Journal of Dermatology|January 19, 2016
Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN)J Schmitt, S Deckert, M Alam, et al.
Pageof 162